Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
GHDx Entry last modified on: Jan 31, 2024
COVID-19
Dataset Records for COVID-19
Displaying 951 - 1000 of 1560
The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the State of Maranhao, Brazil. Preprint
GHDx Entry last modified on: May 12, 2022
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort
GHDx Entry last modified on: Jan 31, 2024
Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with Coronavirus Disease 2019 in New York City
GHDx Entry last modified on: Jan 31, 2024
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain
GHDx Entry last modified on: Mar 14, 2022
Clinical Implications of SARS-CoV-2 Infection in the Viable Preterm Period
GHDx Entry last modified on: Jan 31, 2024
A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization
GHDx Entry last modified on: Jan 31, 2024
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey
GHDx Entry last modified on: May 12, 2022
[Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic]
Популяционный имм унитет к SARS-CoV-2 среди населения Санкт-Петербурга в период эпидемии COVID-19
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
[Distribution of SARS-CоV-2 seroprevalence among residents of the Republic of Tatarstan during the COVID-19 epidemic period]
Характеристика серопревалентности к SARS-СoV-2 среди населения Республики Татарстан на фоне COVID-19
SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
GHDx Entry last modified on: May 12, 2022
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
GHDx Entry last modified on: Jan 31, 2024
Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China
GHDx Entry last modified on: Mar 14, 2022
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. Preprint
GHDx Entry last modified on: May 12, 2022
COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020-April, 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint
GHDx Entry last modified on: May 12, 2022
Post-COVID-19 symptoms 6months after acute infection among hospitalized and non-hospitalized patients
GHDx Entry last modified on: Apr 10, 2023
Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city
GHDx Entry last modified on: Jan 31, 2024
Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India
GHDx Entry last modified on: Apr 10, 2023
Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020
GHDx Entry last modified on: May 12, 2022
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
GHDx Entry last modified on: Jan 31, 2024
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
GHDx Entry last modified on: Apr 14, 2022
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
GHDx Entry last modified on: Jun 24, 2022
Maternal and Neonatal Outcomes of COVID-19 in Pregnancy: A Single-Centre Observational Study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Infection During Pregnancy and Associated Perinatal Health Outcomes: A National US Cohort Study
GHDx Entry last modified on: Apr 10, 2023
Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection
GHDx Entry last modified on: Jan 31, 2024
Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women
GHDx Entry last modified on: Apr 10, 2023
The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey
GHDx Entry last modified on: Apr 10, 2023
Effects of population mobility on the COVID-19 spread in Brazil
GHDx Entry last modified on: Apr 10, 2023
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
GHDx Entry last modified on: Mar 22, 2024
Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization
GHDx Entry last modified on: Mar 22, 2024
Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6months
GHDx Entry last modified on: Mar 22, 2024
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
GHDx Entry last modified on: Mar 22, 2024
Long-term cognitive and functional status in Danish ICU patients with COVID-19
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital
GHDx Entry last modified on: Mar 14, 2022
Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
GHDx Entry last modified on: Jan 31, 2024
Subscribe